Dow manufactures and sells chemicals, plastic materials, and agricultural services. They deliver products and services to customers in electronics, water, energy, coatings, and agriculture. They specialize in materials science to deliver solutions for customers in packaging, infrastructure, and consumer care.

Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (doing business as Chia Tai-Tianqing Pharmaceutical Co Ltd) is a company headquartered in Lianyungang, China. The firm manufactures pharmaceutical products. It was founded in 1969. Kang Xin Yu is the current CEO of the firm.

Gambro is a global medical technology company and a leader in developing, manufacturing and supplying products and therapies for Kidney and Liver dialysis, Myeloma Kidney Therapy, and other extracorporeal therapies for Chronic and Acute patients. Kidney (renal) dialysis was the world’s first extracorporeal therapy (i.e. a therapy that treats organ failure outside the body). Dialysis saves the lives of a growing number of patients every year, and innovation in the field is essential. The only current alternative to renal dialysis - kidney transplantation - is not an available option for most patients, due to a shortage of donor organs. Dialysis technology is now being developed for new applications such as liver dialysis and an emerging field of other extracorporeal therapies, to remove different fluids and toxins from chronically and acutely ill patients. For decades, Gambro has been first to market with many groundbreaking innovations. By designing and delivering solutions to dialysis clinics and intensive care units, Gambro offers not just improved treatment quality, but also improved efficiency. Gambro was founded in 1964 and has today 8 000 employees, 13 production facilities in 9 countries, and sales in more than 90 countries.

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.

Liposome Technology, Inc. is a private company headquartered in Menlo Park, CA. The firm provides computer related services.

Suzhou Ogilvy Material Technology Co., Ltd., established on 2010-08-31, Business scope includes research and development,manufacture:Flat Panel Display Materials,polycarbonate,Polymethylmethacrylate,Polyester optical film products and polymer functional materials,And provide related technology and after-sales service;Sales:Plastic materials,Non-hazardous chemical products,Plastic machinery,plastic film,Sheet;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Jiangsu Academy of Agricultural Sciences is a Chinese private company located in Nanjing, with subsidiaries in China, that engages in agriculture research and development.

Provides on-site non-cryogenic industrial gas generation systems for a wide range of applications

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.

Nissin Electric Co., Ltd. engages in the manufacture and sale of electrical equipment and instruments. It operates through the following segments: Power Equipment, Beam and Vacuum-applied Equipment, New Energy and Environment, and Life Cycle Engineering. The Power Equipment segment includes switchboards, transformers, relays, circuit breakers, switches, capacitor equipment, reactors, and smart power supply systems. The Beam and Vacuum-applied Equipment segment deals with ion implanters for semiconductor and FPD manufacturing, electron beam radiation devices, and thin film coating devices. The New Energy and Environment segment sells photovoltaic power generation systems, power conditioners, power failure countermeasure devices, water treatment electrical equipment, and monitoring control systems. The Life Cycle Engineering segment includes after-sales services such as construction adjustment, maintenance, and inspection. The company was founded in November 1910 and is headquartered in Kyoto, Japan.

Teijin Ltd. engages in the management of its group companies that are involved in the environment and energy, safety and protection, information and electronics, transportation, and healthcare businesses. It operates through the following segments: Materials, Healthcare, and Others. The Materials segment handles the manufacture and sale of polyester, aramid, and carbon fiber products as well as plastic and resin products from polycarbonate resin and polyester film. The Healthcare segment deals with the manufacture and sale of pharmaceuticals and home medical equipment. It also provides home healthcare services. The Others segment offers information technology services. The company was founded by Seita Kumura, Itsuzo Hata, and Naokichi Kaneko on June 17, 1918 and is headquartered in Osaka, Japan.

Anhui Jinghe Biopharmaceutical Technology Co., Ltd., established on 2018-11-27, The scope of business includes mainly engaged in biological,Technology development in the field of medicine,Technical Services,technology transfer,technical consulting;Medical Research and Experimental Development;chemical reagent,Detection Reagent,biological reagent,medical instruments,cosmetic,Chinese patent medicine,Chinese Herbal Medicine,Chemical raw materials and their preparations,biochemical drug,Biological product,Health food research and development,production and sales;Chemical Products(Does not contain a class of precursor chemicals and dangerous goods),Equipment,electronic product,Wujinjiaodian sales;Self-operated and agent goods or technology import and export(Except for national prohibitions and restrictions);Plant Tissue Culture.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Matsushita Electronics Corp. develops and manufactures electronic products. Its products include plasma TVs, DVD players, and digital cameras. It is a subsidiary of Matsushita Electric Industrial Co. Ltd. The company is headquartered in Osaka, Japan.

NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.

Paul GmbH & Co. KG, a subsidiary of Ruppel GmbH & Co. KG, is a German company located in Steinau an der Strasse. The firm manufactures screening machines. It was founded in 1953 by Hans Paul, Hans Arnold and Werner Seyfert. Peter W. Ruppel and Garvin Ruppel are the current co-CEOs of the firm. Paul GmbH & Co. KG was acquired by Ruppel GmbH & Co. KG on February 16, 2021.